A detailed history of Kingsview Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 45,272 shares of AMGN stock, worth $11.9 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
45,272
Previous 32,842 37.85%
Holding current value
$11.9 Million
Previous $10.3 Million 42.16%
% of portfolio
0.33%
Previous 0.26%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $3.85 Million - $4.19 Million
12,430 Added 37.85%
45,272 $14.6 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $8.04 Million - $9.77 Million
-30,610 Reduced 48.24%
32,842 $10.3 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $1.56 Million - $1.89 Million
5,819 Added 10.1%
63,452 $18 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $2.12 Million - $2.39 Million
8,282 Added 16.78%
57,633 $16.6 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $956,812 - $1.19 Million
4,376 Added 9.73%
49,351 $13.3 Million
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $60,209 - $71,196
281 Added 0.63%
44,975 $9.99 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $386,552 - $471,142
-1,712 Reduced 3.69%
44,694 $10.8 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $239,565 - $304,396
1,046 Added 2.31%
46,406 $12.2 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $356,442 - $402,002
1,588 Added 3.63%
45,360 $10.2 Million
Q2 2022

Aug 16, 2022

BUY
$230.71 - $256.74 $340,527 - $378,948
1,476 Added 3.49%
43,772 $10.7 Million
Q1 2022

Feb 08, 2024

SELL
$219.27 - $242.57 $3.29 Million - $3.63 Million
-14,982 Reduced 26.0%
42,651 $10.3 Million
Q4 2021

Feb 17, 2022

BUY
$198.88 - $227.6 $345,852 - $395,796
1,739 Added 4.29%
42,296 $9.52 Million
Q3 2021

Dec 03, 2021

BUY
$212.27 - $248.7 $372,321 - $436,219
1,754 Added 4.52%
40,557 $8.63 Million
Q2 2021

Aug 17, 2021

SELL
$233.58 - $259.14 $1.27 Million - $1.41 Million
-5,443 Reduced 12.3%
38,803 $9.57 Million
Q1 2021

May 24, 2021

BUY
$221.91 - $258.6 $800,429 - $932,770
3,607 Added 8.88%
44,246 $11 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $314,183 - $374,136
-1,452 Reduced 3.45%
40,639 $9.34 Million
Q3 2020

Nov 19, 2020

BUY
$234.65 - $260.95 $548,846 - $610,362
2,339 Added 5.88%
42,091 $10.7 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $390,674 - $479,411
-1,975 Reduced 4.73%
39,752 $9.38 Million
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $4.48 Million - $5.94 Million
24,572 Added 143.24%
41,727 $8.46 Million
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $1.38 Million - $1.77 Million
7,285 Added 73.81%
17,155 $4.14 Million
Q4 2019

Jan 30, 2020

SELL
$189.21 - $243.2 $639,529 - $822,016
-3,380 Reduced 25.51%
9,870 $1.15 Million
Q3 2019

Jan 29, 2020

BUY
$174.11 - $208.62 $197,266 - $236,366
1,133 Added 9.35%
13,250 $2.56 Million
Q2 2019

Jan 29, 2020

BUY
$166.7 - $195.41 $81,016 - $94,969
486 Added 4.18%
12,117 $2.23 Million
Q1 2019

Jan 29, 2020

BUY
$180.87 - $203.88 $411,660 - $464,030
2,276 Added 24.33%
11,631 $2.21 Million
Q4 2018

Jan 29, 2020

BUY
$178.4 - $208.25 $49,238 - $57,477
276 Added 3.04%
9,355 $1.82 Million
Q3 2018

Jan 29, 2020

BUY
$185.29 - $208.89 $34,278 - $38,644
185 Added 2.08%
9,079 $1.88 Million
Q2 2018

Jan 29, 2020

BUY
$166.05 - $186.51 $730,786 - $820,830
4,401 Added 97.95%
8,894 $1.64 Million
Q1 2018

Jan 29, 2020

SELL
$169.43 - $198.0 $911,025 - $1.06 Million
-5,377 Reduced 54.48%
4,493 $766,000
Q4 2017

Jan 29, 2020

BUY
$168.79 - $188.59 $1.32 Million - $1.47 Million
7,800 Added 376.81%
9,870 $1.15 Million
Q3 2017

Jan 29, 2020

SELL
$167.29 - $191.0 $136,675 - $156,047
-817 Reduced 28.3%
2,070 $386,000
Q2 2017

Jan 29, 2020

BUY
N/A
1,100 Added 61.56%
2,887 $497,000
Q1 2017

Jan 29, 2020

BUY
N/A
1,787
1,787 $293,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.